The global Next Generation Cancer Treatment market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Next Generation Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Next Generation Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Cancer Treatment. This report contains market size and forecasts of Next Generation Cancer Treatment in global, including the following market information:
Global Next Generation Cancer Treatment market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Next Generation Cancer Treatment companies in 2024 (%)
Total Market by Segment:
Global Next Generation Cancer Treatment market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Next Generation Cancer Treatment market segment percentages, by Type, 2024 (%)
CAR-T Therapy
Targeted Cancer Therapy
Others
Global Next Generation Cancer Treatment market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Next Generation Cancer Treatment market segment percentages, by Application, 2024 (%)
Lung Cancer
Colorectal Cancer
Stomach Cancer
Breast Cancer
Liver Cancer
Others
Global Next Generation Cancer Treatment market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Next Generation Cancer Treatment market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Next Generation Cancer Treatment revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Next Generation Cancer Treatment revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
OncoGenex Pharmaceuticals, Inc.
Cytokinetics Inc.
Hospira Inc.
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
Bayer HealthCare AG
Abbott Laboratories
Walking Fish Therapeutics
Kojin Therapeutics
Scorpion Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Next Generation Cancer Treatment, market overview.
Chapter 2: Global Next Generation Cancer Treatment market size in revenue.
Chapter 3: Detailed analysis of Next Generation Cancer Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Next Generation Cancer Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Next Generation Cancer Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Next Generation Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Next Generation Cancer Treatment Overall Market Size
2.1 Global Next Generation Cancer Treatment Market Size: 2024 VS 2032
2.2 Global Next Generation Cancer Treatment Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Next Generation Cancer Treatment Players in Global Market
3.2 Top Global Next Generation Cancer Treatment Companies Ranked by Revenue
3.3 Global Next Generation Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Next Generation Cancer Treatment Companies in Global Market, by Revenue in 2024
3.5 Global Companies Next Generation Cancer Treatment Product Type
3.6 Tier 1, Tier 2, and Tier 3 Next Generation Cancer Treatment Players in Global Market
3.6.1 List of Global Tier 1 Next Generation Cancer Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Next Generation Cancer Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Next Generation Cancer Treatment Market Size Markets, 2024 & 2032
4.1.2 CAR-T Therapy
4.1.3 Targeted Cancer Therapy
4.1.4 Others
4.2 Segmentation by Type - Global Next Generation Cancer Treatment Revenue & Forecasts
4.2.1 Segmentation by Type - Global Next Generation Cancer Treatment Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Next Generation Cancer Treatment Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Next Generation Cancer Treatment Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Next Generation Cancer Treatment Market Size, 2024 & 2032
5.1.2 Lung Cancer
5.1.3 Colorectal Cancer
5.1.4 Stomach Cancer
5.1.5 Breast Cancer
5.1.6 Liver Cancer
5.1.7 Others
5.2 Segmentation by Application - Global Next Generation Cancer Treatment Revenue & Forecasts
5.2.1 Segmentation by Application - Global Next Generation Cancer Treatment Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Next Generation Cancer Treatment Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Next Generation Cancer Treatment Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Next Generation Cancer Treatment Market Size, 2024 & 2032
6.2 By Region - Global Next Generation Cancer Treatment Revenue & Forecasts
6.2.1 By Region - Global Next Generation Cancer Treatment Revenue, 2020-2025
6.2.2 By Region - Global Next Generation Cancer Treatment Revenue, 2026-2032
6.2.3 By Region - Global Next Generation Cancer Treatment Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Next Generation Cancer Treatment Revenue, 2020-2032
6.3.2 United States Next Generation Cancer Treatment Market Size, 2020-2032
6.3.3 Canada Next Generation Cancer Treatment Market Size, 2020-2032
6.3.4 Mexico Next Generation Cancer Treatment Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Next Generation Cancer Treatment Revenue, 2020-2032
6.4.2 Germany Next Generation Cancer Treatment Market Size, 2020-2032
6.4.3 France Next Generation Cancer Treatment Market Size, 2020-2032
6.4.4 U.K. Next Generation Cancer Treatment Market Size, 2020-2032
6.4.5 Italy Next Generation Cancer Treatment Market Size, 2020-2032
6.4.6 Russia Next Generation Cancer Treatment Market Size, 2020-2032
6.4.7 Nordic Countries Next Generation Cancer Treatment Market Size, 2020-2032
6.4.8 Benelux Next Generation Cancer Treatment Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Next Generation Cancer Treatment Revenue, 2020-2032
6.5.2 China Next Generation Cancer Treatment Market Size, 2020-2032
6.5.3 Japan Next Generation Cancer Treatment Market Size, 2020-2032
6.5.4 South Korea Next Generation Cancer Treatment Market Size, 2020-2032
6.5.5 Southeast Asia Next Generation Cancer Treatment Market Size, 2020-2032
6.5.6 India Next Generation Cancer Treatment Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Next Generation Cancer Treatment Revenue, 2020-2032
6.6.2 Brazil Next Generation Cancer Treatment Market Size, 2020-2032
6.6.3 Argentina Next Generation Cancer Treatment Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Next Generation Cancer Treatment Revenue, 2020-2032
6.7.2 Turkey Next Generation Cancer Treatment Market Size, 2020-2032
6.7.3 Israel Next Generation Cancer Treatment Market Size, 2020-2032
6.7.4 Saudi Arabia Next Generation Cancer Treatment Market Size, 2020-2032
6.7.5 UAE Next Generation Cancer Treatment Market Size, 2020-2032
7 Companies Profiles
7.1 OncoGenex Pharmaceuticals, Inc.
7.1.1 OncoGenex Pharmaceuticals, Inc. Corporate Summary
7.1.2 OncoGenex Pharmaceuticals, Inc. Business Overview
7.1.3 OncoGenex Pharmaceuticals, Inc. Next Generation Cancer Treatment Major Product Offerings
7.1.4 OncoGenex Pharmaceuticals, Inc. Next Generation Cancer Treatment Revenue in Global Market (2020-2025)
7.1.5 OncoGenex Pharmaceuticals, Inc. Key News & Latest Developments
7.2 Cytokinetics Inc.
7.2.1 Cytokinetics Inc. Corporate Summary
7.2.2 Cytokinetics Inc. Business Overview
7.2.3 Cytokinetics Inc. Next Generation Cancer Treatment Major Product Offerings
7.2.4 Cytokinetics Inc. Next Generation Cancer Treatment Revenue in Global Market (2020-2025)
7.2.5 Cytokinetics Inc. Key News & Latest Developments
7.3 Hospira Inc.
7.3.1 Hospira Inc. Corporate Summary
7.3.2 Hospira Inc. Business Overview
7.3.3 Hospira Inc. Next Generation Cancer Treatment Major Product Offerings
7.3.4 Hospira Inc. Next Generation Cancer Treatment Revenue in Global Market (2020-2025)
7.3.5 Hospira Inc. Key News & Latest Developments
7.4 GlaxoSmithKline plc
7.4.1 GlaxoSmithKline plc Corporate Summary
7.4.2 GlaxoSmithKline plc Business Overview
7.4.3 GlaxoSmithKline plc Next Generation Cancer Treatment Major Product Offerings
7.4.4 GlaxoSmithKline plc Next Generation Cancer Treatment Revenue in Global Market (2020-2025)
7.4.5 GlaxoSmithKline plc Key News & Latest Developments
7.5 Boehringer Ingelheim GmbH
7.5.1 Boehringer Ingelheim GmbH Corporate Summary
7.5.2 Boehringer Ingelheim GmbH Business Overview
7.5.3 Boehringer Ingelheim GmbH Next Generation Cancer Treatment Major Product Offerings
7.5.4 Boehringer Ingelheim GmbH Next Generation Cancer Treatment Revenue in Global Market (2020-2025)
7.5.5 Boehringer Ingelheim GmbH Key News & Latest Developments
7.6 Bayer HealthCare AG
7.6.1 Bayer HealthCare AG Corporate Summary
7.6.2 Bayer HealthCare AG Business Overview
7.6.3 Bayer HealthCare AG Next Generation Cancer Treatment Major Product Offerings
7.6.4 Bayer HealthCare AG Next Generation Cancer Treatment Revenue in Global Market (2020-2025)
7.6.5 Bayer HealthCare AG Key News & Latest Developments
7.7 Abbott Laboratories
7.7.1 Abbott Laboratories Corporate Summary
7.7.2 Abbott Laboratories Business Overview
7.7.3 Abbott Laboratories Next Generation Cancer Treatment Major Product Offerings
7.7.4 Abbott Laboratories Next Generation Cancer Treatment Revenue in Global Market (2020-2025)
7.7.5 Abbott Laboratories Key News & Latest Developments
7.8 Walking Fish Therapeutics
7.8.1 Walking Fish Therapeutics Corporate Summary
7.8.2 Walking Fish Therapeutics Business Overview
7.8.3 Walking Fish Therapeutics Next Generation Cancer Treatment Major Product Offerings
7.8.4 Walking Fish Therapeutics Next Generation Cancer Treatment Revenue in Global Market (2020-2025)
7.8.5 Walking Fish Therapeutics Key News & Latest Developments
7.9 Kojin Therapeutics
7.9.1 Kojin Therapeutics Corporate Summary
7.9.2 Kojin Therapeutics Business Overview
7.9.3 Kojin Therapeutics Next Generation Cancer Treatment Major Product Offerings
7.9.4 Kojin Therapeutics Next Generation Cancer Treatment Revenue in Global Market (2020-2025)
7.9.5 Kojin Therapeutics Key News & Latest Developments
7.10 Scorpion Therapeutics
7.10.1 Scorpion Therapeutics Corporate Summary
7.10.2 Scorpion Therapeutics Business Overview
7.10.3 Scorpion Therapeutics Next Generation Cancer Treatment Major Product Offerings
7.10.4 Scorpion Therapeutics Next Generation Cancer Treatment Revenue in Global Market (2020-2025)
7.10.5 Scorpion Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Next Generation Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Next Generation Cancer Treatment Market Drivers in Global Market
Table 3. Next Generation Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Next Generation Cancer Treatment in Global Market
Table 5. Top Next Generation Cancer Treatment Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Next Generation Cancer Treatment Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Next Generation Cancer Treatment Revenue Share by Companies, 2020-2025
Table 8. Global Companies Next Generation Cancer Treatment Product Type
Table 9. List of Global Tier 1 Next Generation Cancer Treatment Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Next Generation Cancer Treatment Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Next Generation Cancer Treatment Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Next Generation Cancer Treatment Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Next Generation Cancer Treatment Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Next Generation Cancer Treatment Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Next Generation Cancer Treatment Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Next Generation Cancer Treatment Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Next Generation Cancer Treatment Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Next Generation Cancer Treatment Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Next Generation Cancer Treatment Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Next Generation Cancer Treatment Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Next Generation Cancer Treatment Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Next Generation Cancer Treatment Revenue, (US$, Mn), 2026-2032
Table 30. OncoGenex Pharmaceuticals, Inc. Corporate Summary
Table 31. OncoGenex Pharmaceuticals, Inc. Next Generation Cancer Treatment Product Offerings
Table 32. OncoGenex Pharmaceuticals, Inc. Next Generation Cancer Treatment Revenue (US$, Mn) & (2020-2025)
Table 33. OncoGenex Pharmaceuticals, Inc. Key News & Latest Developments
Table 34. Cytokinetics Inc. Corporate Summary
Table 35. Cytokinetics Inc. Next Generation Cancer Treatment Product Offerings
Table 36. Cytokinetics Inc. Next Generation Cancer Treatment Revenue (US$, Mn) & (2020-2025)
Table 37. Cytokinetics Inc. Key News & Latest Developments
Table 38. Hospira Inc. Corporate Summary
Table 39. Hospira Inc. Next Generation Cancer Treatment Product Offerings
Table 40. Hospira Inc. Next Generation Cancer Treatment Revenue (US$, Mn) & (2020-2025)
Table 41. Hospira Inc. Key News & Latest Developments
Table 42. GlaxoSmithKline plc Corporate Summary
Table 43. GlaxoSmithKline plc Next Generation Cancer Treatment Product Offerings
Table 44. GlaxoSmithKline plc Next Generation Cancer Treatment Revenue (US$, Mn) & (2020-2025)
Table 45. GlaxoSmithKline plc Key News & Latest Developments
Table 46. Boehringer Ingelheim GmbH Corporate Summary
Table 47. Boehringer Ingelheim GmbH Next Generation Cancer Treatment Product Offerings
Table 48. Boehringer Ingelheim GmbH Next Generation Cancer Treatment Revenue (US$, Mn) & (2020-2025)
Table 49. Boehringer Ingelheim GmbH Key News & Latest Developments
Table 50. Bayer HealthCare AG Corporate Summary
Table 51. Bayer HealthCare AG Next Generation Cancer Treatment Product Offerings
Table 52. Bayer HealthCare AG Next Generation Cancer Treatment Revenue (US$, Mn) & (2020-2025)
Table 53. Bayer HealthCare AG Key News & Latest Developments
Table 54. Abbott Laboratories Corporate Summary
Table 55. Abbott Laboratories Next Generation Cancer Treatment Product Offerings
Table 56. Abbott Laboratories Next Generation Cancer Treatment Revenue (US$, Mn) & (2020-2025)
Table 57. Abbott Laboratories Key News & Latest Developments
Table 58. Walking Fish Therapeutics Corporate Summary
Table 59. Walking Fish Therapeutics Next Generation Cancer Treatment Product Offerings
Table 60. Walking Fish Therapeutics Next Generation Cancer Treatment Revenue (US$, Mn) & (2020-2025)
Table 61. Walking Fish Therapeutics Key News & Latest Developments
Table 62. Kojin Therapeutics Corporate Summary
Table 63. Kojin Therapeutics Next Generation Cancer Treatment Product Offerings
Table 64. Kojin Therapeutics Next Generation Cancer Treatment Revenue (US$, Mn) & (2020-2025)
Table 65. Kojin Therapeutics Key News & Latest Developments
Table 66. Scorpion Therapeutics Corporate Summary
Table 67. Scorpion Therapeutics Next Generation Cancer Treatment Product Offerings
Table 68. Scorpion Therapeutics Next Generation Cancer Treatment Revenue (US$, Mn) & (2020-2025)
Table 69. Scorpion Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Next Generation Cancer Treatment Product Picture
Figure 2. Next Generation Cancer Treatment Segment by Type in 2024
Figure 3. Next Generation Cancer Treatment Segment by Application in 2024
Figure 4. Global Next Generation Cancer Treatment Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Next Generation Cancer Treatment Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Next Generation Cancer Treatment Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Next Generation Cancer Treatment Revenue in 2024
Figure 9. Segmentation by Type � Global Next Generation Cancer Treatment Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Next Generation Cancer Treatment Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Next Generation Cancer Treatment Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Next Generation Cancer Treatment Revenue Market Share, 2020-2032
Figure 13. By Region - Global Next Generation Cancer Treatment Revenue Market Share, 2020-2032
Figure 14. By Country - North America Next Generation Cancer Treatment Revenue Market Share, 2020-2032
Figure 15. United States Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Next Generation Cancer Treatment Revenue Market Share, 2020-2032
Figure 19. Germany Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 20. France Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Next Generation Cancer Treatment Revenue Market Share, 2020-2032
Figure 27. China Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 31. India Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Next Generation Cancer Treatment Revenue Market Share, 2020-2032
Figure 33. Brazil Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Next Generation Cancer Treatment Revenue Market Share, 2020-2032
Figure 36. Turkey Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Next Generation Cancer Treatment Revenue, (US$, Mn), 2020-2032
Figure 40. OncoGenex Pharmaceuticals, Inc. Next Generation Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Cytokinetics Inc. Next Generation Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Hospira Inc. Next Generation Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. GlaxoSmithKline plc Next Generation Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Boehringer Ingelheim GmbH Next Generation Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Bayer HealthCare AG Next Generation Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Abbott Laboratories Next Generation Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Walking Fish Therapeutics Next Generation Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Kojin Therapeutics Next Generation Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Scorpion Therapeutics Next Generation Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
